1. Home
  2. SGRP vs OSRH Comparison

SGRP vs OSRH Comparison

Compare SGRP & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.61

Market Cap

14.5M

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.60

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRP
OSRH
Founded
1967
N/A
Country
United States
United States
Employees
N/A
21
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
11.7M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SGRP
OSRH
Price
$0.61
$0.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.6K
850.3K
Earning Date
03-31-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$136,104,000.00
N/A
Revenue This Year
N/A
$9.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.38
52 Week High
$1.41
$1.79

Technical Indicators

Market Signals
Indicator
SGRP
OSRH
Relative Strength Index (RSI) 45.37 63.75
Support Level $0.50 $0.54
Resistance Level $0.83 $0.60
Average True Range (ATR) 0.06 0.06
MACD 0.01 0.01
Stochastic Oscillator 63.12 86.28

Price Performance

Historical Comparison
SGRP
OSRH

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. The company provides five principal types of services: Merchandising, Marketing and Category Management, Remodel and Retail Transformation, Assembly and Installation, Fulfilment and Distribution, and Business Analytics and Insights. It operates in two segments, namely the U.S. and Canada, with the majority of the revenues deriving from the U.S. segment.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: